- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT05016570
The Impact of Picture Narrative Format on Print Lung Screening Communication Outcomes
The Impact of Picture Narrative Format on Knowledge and Acceptability for Lung Screening Print Decision Support Materials
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
Population screening is key to detecting lung cancer early at a more treatable stage. Uptake of screening should be equitable (i.e., screening benefits all eligible members of the population and does not contribute further to health disparities) and informed (i.e., participants have been involved in the decision to take part and their decision aligns with their values and circumstances). Print decision support materials are the primary mechanism for encouraging engagement with cancer screening and supporting decision making. It is essential that we identify print communication techniques that are effective in informing invitees about lung screening.
The intervention, picture narrative information about lung screening, was previously developed through codesign and prototype testing with people likely to be eligible for lung screening (50 to 75 years old, past or current heavy smokers). Participants will be randomised to one of three groups: Picture narrative format, Text with pictures (control 1) or, Text-only (control 2). This study will assess whether presenting lung screening information in a picture narrative format can improve lung cancer screening knowledge, eligibility self-assessment and attitudes. It will also assess whether perceptions of the information designs can explain any impact of the intervention on these outcomes and whether there are differences across socioeconomic groups.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
-
Glasgow, Storbritannien, G12 0XH
- Mental Health and Wellbeing, University of Glasgow
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Living in Glasgow
- Willing and able to respond unaided to invitation to participate in the trial and give informed consent.
- Aged between 49 and 75 years
Exclusion Criteria:
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Hälsovårdsforskning
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Picture narrative lung screening information
Participants in this arm receive information about lung screening purpose, eligibility, benefits and risks in a format which uses text in combination with sequences of pictures to communicate a coherent message.
The designs follow conventions from comics/graphic narratives and key stakeholders were involved during the design process.
|
Lung screening information formatted as picture narratives
|
|
Aktiv komparator: Text with pictures lung screening information
Participants in this arm receive information about lung screening purpose, eligibility, benefits and risks in a format that uses text with non-narrative pictures for decoration.
The pictures have been extracted from the picture narratives being used Arm 1.
|
Lung screening information formatted as text and non-narrative pictures
|
|
Aktiv komparator: Text-only lung screening information
Participants in this arm receive information about lung screening purpose, eligibility, benefits and risks in a format that uses text and no pictures.
|
Lung screening information formatted as text with no pictures
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Participant Lung Cancer Screening Knowledge scores
Tidsram: Immediately post-intervention
|
Participants will be asked 6 multiple choice questions related to the lung screening information presented to the participants during the intervention, covering; Procedure, Eligibility - who, Eligibility - why, Benefits, Adverse effects, Potential results.
|
Immediately post-intervention
|
|
Lung Cancer Screening Eligibility self-assessment
Tidsram: Immediately post-intervention
|
Concordance between self-reported personal eligibility for lung cancer screening and actual eligibility based on self-reported age and smoking behaviour.
|
Immediately post-intervention
|
|
Participant Lung Cancer Screening Attitudes
Tidsram: Immediately post-intervention
|
Self-administered four-item lung cancer screening attitudes measure covering cancer fear, fatalism, benefits, and worry, previously used by Smits et al 2018.
|
Immediately post-intervention
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Participant Design appraisal ratings
Tidsram: Immediately post-intervention
|
Self-administered nine-item measure rating perceptions of appeal, enjoyment, interest, ease of use, trustworthiness, appropriateness, helpfulness, informativity. Alongside a single item asking participants whether enough information was provided. |
Immediately post-intervention
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Treatment compliance
Tidsram: Immediately post-intervention
|
Self-reported length of time spent reading the lung screening information.
|
Immediately post-intervention
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Kathryn Robb, PhD, University of Glasgow
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- 200200021
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Tidsram för IPD-delning
Kriterier för IPD Sharing Access
IPD-delning som stöder informationstyp
- STUDY_PROTOCOL
- ICF
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .